Evotec
Vivien L. is a highly experienced professional in the field of drug discovery, currently serving as Senior Project Manager in Integrated Drug Discovery at Evotec since February 2020, following roles as Senior Research Scientist and Research Scientist in project leadership. Prior to this, Vivien L. was a Postdoctoral Research Fellow at the MRC Toxicology Unit, focusing on cancer research and studying the role of p73 in glioblastoma. Academic accomplishments include a PhD in Molecular Medicine/Oncology from The University of Edinburgh, complemented by a Master's degree in Biomedical Sciences from Edinburgh Napier University and a Bachelor's degree in Life Science from Leibniz Universität Hannover. Additional experience includes visiting researcher positions at A*STAR in Singapore, specializing in molecular modeling and simulation techniques.
This person is not in the org chart
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.